Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


Cell Culture & Bioprocessing Congress

05 Nov 2012 - 06 Nov 2012 - London, UK



Bookmark and Share


175 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

50 presentations, case studies and panel discussions focused on the key issues in cell line optimisation, process development and biological production

4 interactive streams:
•    Cell line development x2
•    Upstream process development
•    Biological production

14 prescheduled one to one meetings, Q&A sessions and exhibition spaces creating a unique platform for business and scientific discussion

Oxford Global Conferences are proud to present our Cell Culture & Bioprocessing Congress, taking place on 5th & 6th November, 2012 at the CBI Conference Centre in London.

Experts predict that the cell culture sector will be worth over $6 billion by 2015. The growth of the biopharma industry as whole, combined with the increasingly wide reach of cell culture applications has secured a prominent role for cell culture and bioprocessing in the pharmaceutical industry of the future.
This event is designed to offer clear and informed insights into the trends and solutions most relevant to those working in the industry. The conference programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, creating an interactive platform for high-level scientific and business discussion.

On Day One, our panel of cell engineering experts will discuss vector design, genome engineering and high throughput technologies. Delegates will also hear from those working at the forefront of process innovation, in areas such as disposable reactors, next generation fermentation and process characterisation.

Day Two will feature presentations covering the critical opportunities in cell line optimisation including, miniaturised systems, 3D cell culture and bioinformatic analysis. Our highly esteemed speakers will also explore the key challenges in biological production; topics will include CMO relationship management, technology transfer and the role of single-use technology.

The Cell Culture & Bioprocessing Congress is part of the highly successful Oxford Global Proteins Series.



Further information
Scientific News
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Crouching Protein, Hidden Enzyme
A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Engineering Foe into Friend
Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!